SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-15-007465
Filing Date
2015-04-16
Accepted
2015-04-16 08:09:29
Documents
8
Period of Report
2015-05-28
Effectiveness Date
2015-04-16

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pdli20150409_def14a.htm DEF 14A 1431109
2 a2.jpg GRAPHIC 130707
3 a1.jpg GRAPHIC 135772
4 pdli20150409_def14aimg002.gif GRAPHIC 2504
5 chart.jpg GRAPHIC 30489
6 pdli20150409_def14aimg006.gif GRAPHIC 2504
7 sig.jpg GRAPHIC 3893
8 pdlbio.jpg GRAPHIC 8326
  Complete submission text file 0001437749-15-007465.txt   1865991
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19756 | Film No.: 15773294
SIC: 2836 Biological Products, (No Diagnostic Substances)